Bristol Myers Squibb has expanded into the neuroscience sector with its updated ...
Novartis and the Novartis US Foundation have undergone a substantial expansion o...
Acumen Pharmaceuticals recently unveiled early clinical evidence showcasing the ...
Incyte is attempting to enter the competitive market for atopic dermatitis with ...
After an initial deal of $81 million in June 2022, Novartis and Samsung have dec...
After experiencing trouble with observations in February, Outset Medical has rec...
Sino-American biotech company BeiGene has announced its acquisition of China-bas...
The Food and Drug Administration (FDA) in the U.S. has completely lifted the par...
Travelers and medical professionals from the U.S. who are hoping for a different...
According to the results of a late-stage clinical trial, Opdivo, an immunotherap...
Tessa Therapeutics, a biotech company based in Singapore, has halted its operati...
The European Medicines Agency (EMA) has launched a thorough review of Novo Nordi...
Renalytix has achieved a significant milestone after a challenging three-year jo...
J&J shared results from its phase 2 trial for JNJ-2113, an oral psoriasis drug f...
Amneal Pharmaceuticals were positive about launching their extended-release trea...
AstraZeneca announced the main findings of a Phase III trial for an antibody-dru...
